The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency's drug program, the latest in a string of leadership changes at the agency.

A standoff over Elevidys could have major consequences for Duchenne patients, gene therapy companies and the perception of ...

FDA Commissioner Marty Makary, M.D., has made his pick for the next director of the FDA’s Center for Drug Evaluation and ...

Dr. Vinay Prasad: Bodily Autonomy Applies to Raw Milk, Not Vaccines This is what it looks like when disinformation doctors pretend to value data and science to further their true objective, MAHA ...

Prasad was hired to lead the FDA’s vaccine center in May, after the previous director, Dr. Peter Marks, was forced to resign over disagreements with Kennedy.

Mark Sears, undrafted in 2025, signs a two-way deal with the Bucks. Relive his Alabama glory, including a historic 10 three-pointer game.

Biocryst is offloading part of its business for $250 million. Meanwhile, the former FDA leader took issue with a new policy for COVID-19 shots.

Dr. Peter Marks, Director of the FDA’s Center for Biologics Evaluation and Research (CBER), announced his resignation in a letter dated Friday, March 28, saying he will retire from federal service on ...

A sharpshooter out of Liberty, Taelon Peter shot 45% from behind the arc last season and led the NCAA in true shooting percentage.

That’s what Brooklyn GM Sean Marks did in the first round of the draft. The Nets tanked last season, collected draft assets and went into Wednesday with a record five first-round picks.